Get the Stockscreener App
1.66
26.72%
0.35
After Hours:
1.65
-0.01
-0.60%
Casi Pharmaceuticals Inc stock is traded at $1.66, with a volume of 2.86M.
It is up +26.72% in the last 24 hours and down -28.14% over the past month.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
See More
Previous Close:
$1.31
Open:
$1.35
24h Volume:
2.86M
Relative Volume:
2.30
Market Cap:
$20.42M
Revenue:
$22.06M
Net Income/Loss:
$-30.94M
P/E Ratio:
-0.7411
EPS:
-2.24
Net Cash Flow:
$-26.70M
1W Performance:
+9.21%
1M Performance:
-28.14%
6M Performance:
-23.15%
1Y Performance:
-73.05%
1-Day Range:
$1.25
$1.70
1-Week Range:
$1.21
$1.70
52-Week Range:
$1.0909
$7.50
Casi Pharmaceuticals Inc Stock (CASI) Company Profile
Name
Casi Pharmaceuticals Inc
Sector
Industry
Phone
-
Address
-
Compare CASI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CASI
Casi Pharmaceuticals Inc
|
1.66 | 20.30M | 22.06M | -30.94M | -26.70M | -2.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Casi Pharmaceuticals Inc Stock (CASI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-18-21 | Initiated | BTIG Research | Buy |
| Apr-26-21 | Initiated | Mizuho | Buy |
| Oct-23-20 | Initiated | Oppenheimer | Outperform |
| Sep-22-16 | Initiated | Maxim Group | Buy |
| Oct-29-15 | Resumed | H.C. Wainwright | Buy |
| Jun-23-15 | Initiated | H.C. Wainwright | Buy |
View All
Casi Pharmaceuticals Inc Stock (CASI) Latest News
Can CASI Pharmaceuticals Inc. stock attract ESG capital inflowsMarket Growth Summary & High Conviction Buy Zone Alerts - newser.com
Little Excitement Around CASI Pharmaceuticals, Inc.'s (NASDAQ:CASI) Revenues As Shares Take 43% Pounding - simplywall.st
What analysts say about CASI Pharmaceuticals Inc stockHigh Beta Stocks & Small Investment Capital Tips - earlytimes.in
Does CASI Pharmaceuticals Inc. qualify in momentum factor screening2025 Market Sentiment & Fast Moving Market Watchlists - newser.com
Intraday pattern recognizer results for CASI Pharmaceuticals Inc.Weekly Investment Recap & Expert Curated Trade Ideas - newser.com
Can CASI Pharmaceuticals Inc. hit a new high this monthPortfolio Profit Report & Verified Swing Trading Watchlists - newser.com
Why CASI Pharmaceuticals Inc. stock remains undervaluedWeekly Trend Recap & Comprehensive Market Scan Insights - newser.com
Why CASI Pharmaceuticals Inc. is moving today2025 Growth vs Value & Fast Exit Strategy with Risk Control - newser.com
Will CASI Pharmaceuticals Inc. benefit from macro trendsQuarterly Performance Summary & Fast Moving Trade Plans - newser.com
Is CASI Pharmaceuticals Inc. showing signs of accumulation2025 Market Outlook & Daily Volume Surge Trade Alerts - newser.com
How to interpret RSI for CASI Pharmaceuticals Inc. stockJuly 2025 Market Mood & Reliable Entry Point Alerts - newser.com
Order flow analysis tools used on CASI Pharmaceuticals Inc.July 2025 Selloffs & Verified Trade Idea Suggestions - newser.com
Will CASI Pharmaceuticals Inc. stock maintain dividend yield2025 Winners & Losers & Safe Entry Momentum Tips - newser.com
Why Hedge Funds Are Buying Amerise Biosciences Limited in YEARRisk Mitigation Techniques & Small Budget Trading Tips - earlytimes.in
Trend analysis for CASI Pharmaceuticals Inc. this weekJuly 2025 Snapshot & Fast Moving Stock Watchlists - newser.com
CASI Pharmaceuticals Strengthens Board with Industry Veteran James Huang - TipRanks
James Huang to join CASI Pharmaceuticals board as independent director - Investing.com
James Huang to join CASI Pharmaceuticals board as independent director By Investing.com - Investing.com Canada
CASI Pharmaceuticals Appoints James Huang to Board of Directors - ACCESS Newswire
Casi Pharmaceuticals Inc Stock (CASI) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.36%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):